[go: up one dir, main page]

IL101675A - Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors - Google Patents

Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors

Info

Publication number
IL101675A
IL101675A IL101675A IL10167592A IL101675A IL 101675 A IL101675 A IL 101675A IL 101675 A IL101675 A IL 101675A IL 10167592 A IL10167592 A IL 10167592A IL 101675 A IL101675 A IL 101675A
Authority
IL
Israel
Prior art keywords
neurokinine
receptors
detecting
pharmaceutical compositions
localizing
Prior art date
Application number
IL101675A
Other languages
English (en)
Other versions
IL101675A0 (en
Original Assignee
Mallinckrodt Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Medical Inc filed Critical Mallinckrodt Medical Inc
Publication of IL101675A0 publication Critical patent/IL101675A0/xx
Publication of IL101675A publication Critical patent/IL101675A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/22—Tachykinins, e.g. Eledoisins, Substance P; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
IL101675A 1991-04-22 1992-04-22 Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors IL101675A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91200955 1991-04-22

Publications (2)

Publication Number Publication Date
IL101675A0 IL101675A0 (en) 1992-12-30
IL101675A true IL101675A (en) 1997-11-20

Family

ID=8207620

Family Applications (1)

Application Number Title Priority Date Filing Date
IL101675A IL101675A (en) 1991-04-22 1992-04-22 Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors

Country Status (8)

Country Link
EP (1) EP0584256B1 (xx)
JP (1) JPH06507174A (xx)
AT (1) ATE186550T1 (xx)
AU (1) AU2175492A (xx)
CA (1) CA2106874A1 (xx)
DE (1) DE69230287T2 (xx)
IL (1) IL101675A (xx)
WO (1) WO1992018536A2 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401483D0 (en) * 1994-01-26 1994-03-23 Sandoz Ltd Organic compounds
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
CA2190679A1 (en) * 1996-11-19 1998-05-19 Christopher J. Paige Lymphocyte tachykinin
US6106804A (en) * 1997-06-13 2000-08-22 The University Of New Mexico Arsenic-72 labeled compounds for tissue specific medical imaging
AU2001297873A1 (en) * 2000-11-21 2003-01-02 New England Medical Center Novel antimicrobial compounds
ES2246687B2 (es) * 2004-02-11 2006-11-16 Miguel Muñoz Saez Utilizacion de antagonistas no peptidicos de receptores nk1 para la produccion de apoptosis en celulas tumorales.
US11141494B2 (en) * 2014-08-09 2021-10-12 Purdue Research Foundation Development of neurokinin-1 receptor-binding agent delivery conjugates
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
WO2018096082A1 (en) 2016-11-28 2018-05-31 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
AU2019382881B2 (en) 2018-11-23 2025-06-12 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4481139A (en) * 1983-04-13 1984-11-06 Board Of Regents, The University Of Texas System Peptide antagonists of substance P
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
EP0176436A3 (en) * 1984-09-26 1987-12-16 Merck & Co. Inc. Analogs of substance p and eledoisin
GB8613431D0 (en) * 1986-06-03 1986-07-09 Medical Res Council Human tachykinins
WO1989007456A1 (en) * 1988-02-09 1989-08-24 Mallinckrodt, Inc. Method of preparing a metal-radionuclide-labelled protein
ZA894533B (en) * 1988-06-20 1990-03-28 Merrell Dow Pharma Neurokinin a antogonists

Also Published As

Publication number Publication date
WO1992018536A2 (en) 1992-10-29
CA2106874A1 (en) 1992-10-29
EP0584256A1 (en) 1994-03-02
WO1992018536A3 (en) 1992-11-26
ATE186550T1 (de) 1999-11-15
DE69230287T2 (de) 2000-05-11
JPH06507174A (ja) 1994-08-11
EP0584256B1 (en) 1999-11-10
AU2175492A (en) 1992-11-17
DE69230287D1 (de) 1999-12-16
IL101675A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
TW250435B (xx)
ATE107858T1 (de) Pharmazeutische zusammensetzung zum abnehmen.
CA2045594A1 (en) Immunogenic compositions against gastrin peptides
MY118526A (en) Method for improving the pharmacokinetics of tipranavir
IL101675A0 (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
AU7284098A (en) Method for preventing gastritis using amylin or amylin agonists
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
ZA802807B (en) 6-substituted 11-alkylene-morphanthridines,their preparation,and therapeutic agents containing these compounds
ES2057572T3 (es) Agentes de reconocimiento.
PT1076561E (pt) Terapia de combinacao para o tratamento de tumores
HU9700661D0 (en) Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
DE3462688D1 (en) 1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane useful in combating diseases
DK0406216T3 (da) Protein-S-holdigt farmaceutisk præparat
UA39179C2 (uk) Фармацевтична композиція для лікування порушень серцевого ритму у великих ссавців та людей, спосіб її одержання та антиаритмічний лікарський засіб
IL126158A0 (en) Method for treating substance abuse
MX9303074A (es) Uso de la (e)-2-(p-fluorofenetil)-3-fluoroalilamina en el tratamiento de la enfermedad de elzheimer.
AU3577889A (en) Method of localizing and quantifying regional energy metabolism in a warm-blooded living being and composition therefor
DE3473826D1 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
KR900017599A (ko) 종양 치료용 약학 조성물
BR9713828A (pt) Tratamento de tumores altamente vasculares
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees